Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aura Biosciences, Inc.

6.50
+0.40006.56%
Volume:178.26K
Turnover:1.16M
Market Cap:403.03M
PE:-3.42
High:6.73
Open:6.21
Low:6.05
Close:6.10
Loading ...

Aura Biosciences Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
28 May

Innovative Precision Oncology and Promising Clinical Results Justify Buy Rating for Aura Biosciences Inc

TIPRANKS
·
28 May

Aura Biosciences Price Target Maintained With a $19.00/Share by JMP Securities

Dow Jones
·
23 May

Strategic Positioning and Regulatory Advantage Bolster Aura Biosciences Inc’s Buy Rating

TIPRANKS
·
23 May

Officer Anthony S. Gibney Reports Disposal of Common Shares of Aura Biosciences Inc

Reuters
·
21 May

Aura Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
20 May

Aura Biosciences Advances in Cancer Therapy Trials

TIPRANKS
·
17 May

Aura Biosciences Inc. Files Initial Ownership Statement; Anthony S. Gibney Named as Officer Beneficial Owner

Reuters
·
17 May

Aura Biosciences Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
16 May

Aura Biosciences Inc (AURA) Receives a Buy from Scotiabank

TIPRANKS
·
16 May

TD Cowen Sticks to Their Buy Rating for Aura Biosciences Inc (AURA)

TIPRANKS
·
16 May

BUZZ-U.S. STOCKS ON THE MOVE-Xponential Fitness, Phillips 66, Amazon.com

Reuters
·
16 May

BUZZ-Aura Biosciences climbs after $75 million public offering

Reuters
·
15 May

Aura Biosciences Prices $75 Million Offering of Shares, Warrants

MT Newswires Live
·
15 May

Aura Biosciences 11.7M share Spot Secondary priced at $4.90

TIPRANKS
·
15 May

Aura Biosciences Inc - Prices Public Offering of 11.7 Mln Shares

THOMSON REUTERS
·
15 May

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

THOMSON REUTERS
·
15 May

Aura Biosciences Launches Proposed Public Offering of Shares, Warrants

MT Newswires Live
·
15 May

Aura Biosciences Names Anthony Gibney Chief Financial, Business Officer

Dow Jones
·
15 May

BRIEF-Aura Biosciences Announces Proposed Public Offering Of Common Stock And Warrants

Reuters
·
15 May